Want to join the conversation?
Chip maker $AVGO recorded strong 4Q15 results, its net income rose 218% to $429MM, or $1.49 per share, from $135MM, or $0.50 per share, a year ago, helped by higher revenues. Total revenue rose 16% YoverY to $1.84Bil. $AVGO reported adjusted EPS of $2.51.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.